Interleukin-9 and interleukin-17C in chronic rhinosinusitis

International Forum of Allergy and Rhinology

Volumn 6, Issue 8, 2016, Pages 841-847

  Olcott, Clara M ^a   Han, Joseph K ^a   Cunningham, Tina D ^a   Franzese, Christine B ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

allergic rhinitis; asthma; chronic rhinosinusitis; chronic sinusitis; IL 17; IL 9; immunohistochemistry; interleukins; nasal polyps; sinusitis

Indexed keywords

INTERLEUKIN 17C; INTERLEUKIN 9;

ADULT; AGE DISTRIBUTION; ALLERGY; ARTICLE; ASTHMA; ATOPY; CHRONIC RHINOSINUSITIS; CONTROLLED STUDY; ENDOSCOPIC SINUS SURGERY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NOSE POLYP; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SEX DIFFERENCE; SKIN TEST;

EID: 84980343829     PISSN: 20426976     EISSN: 20426984     Source Type: Journal    
DOI: 10.1002/alr.21745     Document Type: Article

References (20)

1. Bachert C, Patou J, Cauwenberge PV. The role of sinus disease in asthma. Curr Opin Allergy Clin Immunol. 2006;6:29–36.
2. Temann UA, Laouar YE, Eynon E, et al. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J Exp Med. 1998;188:1307–1320.
3. Tsicopoulos A, Shimbara A, de Nadai P, et al. Involvement of IL-9 in the bronchial phenotype of patients with nasal polyposis. J Allergy Clin Immunol. 2004;114:462–469.
4. Aggarwal S, Gurney AL. IL-17:prototype member of an emerging cytokine family. J Leukoc Biol. 2002;71:1–8.
5. Jin J, Rha K-S, Kim DW, Kim YM. IL-17C in nasal epithelial cells of chronic rhinosinusitis with nasal polyposis. Eur Arch Otorhinolaryngol. 2014;271:1097–1105.
6. Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015;152:S1–S39.
7. Makihara S, Okano M, Fujiwara T, et al. Local expression of interleukin-17a is correlated with nasal eosinophilia and clinical severity in allergic rhinitis. Allergy Rhinol (Providence). 2014;5:22–27.
8. Goswami R, Kaplan MH. A brief history of IL-9. J Immunol. 2011;186:3283–3288.
9. Zhao P, Xiao X, Ghobrial RM, Li XC. IL-9 and Th9 cells: progress and challenges. Int Immunol. 2013;25:547–551.
10. Hauber HP, Bergeron C, Toda M, et al. Up-regulation of interleukin-9 and the interleukin-9-associated calcium-activated chloride channel hCLCA1 in nasal mucosa following in vivo allergen challenge. Allergy Asthma Clin Immunol. 2007;3:19–23.
11. Lin H, Lin D, Xiong XS, Dai, XX, Lin T. Expression and regulation of interleukin-9 in chronic rhinosinusitis. Am J Rhinol Allergy. 2015;29:18–23.
12. Ryan MW, Brooks EG. Rhinosinusitis and comorbidities. Curr Allergy Asthma Rep. 2010;10:188–193.
13. Devos S, Cormont F, Vrtala S, et al. Allergen-induced interleukin-9 production in vitro: correlation with atopy in human adults and comparison with interleukin-5 and interleukin-13. Clin Exp Allergy. 2006;36:174–182.
14. Kim MS, Cho KA, Cho YJ, Woo SY. Effects of interkeukin-9 blockade on chronic airway inflammation in murine asthma models. Allergy Asthma Immunol Res. 2013;5:197–206.
15. Parker JM, Oh CK, LaForce C, et al.; MEDI-528 Clinical Trials Group. Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma. BMC Pulm Med. 2011;11:14.
16. Hu XD, Bao YY, Zhou SH, et al. Interleukin-17A expression in patients with chronic rhinosinusitis and its relationship with clinical features. J Int Med Res. 2013;41:777–784.
17. Makihara S, Okano M, Fujiwara T, et al. Regulation and characterization of IL-17A expression in patients with chronic rhinosinusitis and its relationship with eosinophilic inflammation. J Allergy Clin Immunol. 2010;126:397–400.
18. Ciprandi G, Fenoglio D, De Amici M, Quaglini S, Negrini S, Filaci G. Serum IL-17 levels in patients with allergic rhinitis. J Allergy Clin Immunol. 2008;122:650–651.e2.
19. Ciprandi G, De Amici M, Murdaca G, et al. Serum interleukin-17 levels are related to clinical severity in allergic rhinitis. Allergy. 2009;64:1375–1378.
20. Beriou G, Bradshaw EM, Lozano E, et al. TGF-beta induces IL-9 production from human TH17 cells. J Immunol. 2010;185:46–54.